Dr Mel Hughes, from the Centre for Seldom Heard Voices, was asked by Urban Markström and Ulla-Karin to join them as part of an advisory board for a project, for which they have received a six-year research grant regarding service user involvement in community mental health.
All researchers in the research program, called called ‘UserInvolve’ are members of a Swedish research network called Centre for Evidence-based Psychosocial Interventions (CEPI). A couple of times a year, they arrange seminars, where they introduce current themes or discuss a variety of ongoing projects. Participating are both senior and junior researchers, and people with lived experience of mental illness (often representatives from service user organisations).
Mel was invited to present at the seminar series on 10th November 2021 and the session was really well received and triggered a great discussion on parity of participation and how we need to change the research system to make involvement more inclusive. The day after the event, Ulla-Karin said ‘talk in the hallways today is that people are very enthusiastic and inspired by your talk on CEPI, yesterday’.
Mel is now working with Ulla-Karin and other colleagues to Guest edit a Special Issue of the British Journal of Social Work on The Voice and Influence of people with lived experience.
Well done, Mel!
The Friday Prof-ile: Mel Hughes
Lunchtime Seminar: CBT for MS Fatigue – from individual to technology-based interventions – 29th July 2016










Final Bournemouth University publication of 2025
On Christmas Day in the Morning…
New Nepal scoping review on maternal & neonatal health
Fourth INRC Symposium: From Clinical Applications to Neuro-Inspired Computation
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease